Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 3;26(17):8562.
doi: 10.3390/ijms26178562.

Apolipoprotein E Alleles and Motor Signs in Older Adults with Alzheimer's Dementia

Affiliations

Apolipoprotein E Alleles and Motor Signs in Older Adults with Alzheimer's Dementia

Ioannis Liampas et al. Int J Mol Sci. .

Abstract

We investigated associations between apolipoprotein E (APOE) alleles and motor manifestations in Alzheimer's dementia (AD) capitalizing on National Alzheimer's Coordinating Center data: the baseline evaluations of older adults (≥60 years) with a diagnosis of AD were analyzed. Those with a concomitant diagnosis Parkinson's disease or other parkinsonian syndrome, and those treated with anti-parkinsonian agents were excluded. Three APOE groups were formed: APOE2 (APOE2 carriers), APOE3 (APOE3/APOE3) and APOE4 (APOE4/APOE4, APOE4/APOE3). UPDRS-III was used to assess the presence or absence of motor signs in 9 domains. Adjusted binary logistic models featuring the three APOE groups as exposures and motor domains as outcomes were estimated. There were 389 individuals in the APOE2, 1799 in the APOE3 and 2791 in the APOE4 groups. Compared to the APOE2 group, individuals in the APOE4 group had lower odds of having at least one motor sign [0.64 (0.50-0.82)]. Among motor signs, rigidity [0.53 (0.34-0.81)], bradykinesia [0.56 (0.40-0.77)], impaired chair rise [0.54 (0.37-0.78)] and impaired posture-gait [0.54 (0.36, 0.81)] exhibited significant associations. Exploratory analyses featuring APOE genotypes suggested dose-response relationships for both APOE2 and APOE4. In conclusion, APOE2 confers a risk towards motor (mainly parkinsonian) signs in AD. APOE4 may have a protective effect.

Keywords: Alzheimer’s dementia; apolipoprotein E; bradykinesia; gait; motor signs; posture; rigidity; tremor.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Participant flowchart. APOE: apolipoprotein E; UPDRS-III: Unified Parkinson’s disease rating scale part III.
Figure 2
Figure 2
Prevalence [(those with the respective motor sign per genotype/those with the genotype) *100] of motor manifestations per apolipoprotein E (APOE) genotype in older adults with Alzheimer’s dementia. Different APOE genotypes are represented by different colors (see annotation). The prevalence (%) of each motor sign by APOE genotype is also noted in the table of contents below the bar chart.

References

    1. Verghese P.B., Castellano J.M., Holtzman D.M. Apolipoprotein E in Alzheimer’s disease and other neurological disorders. Lancet. Neurol. 2011;10:241–252. doi: 10.1016/S1474-4422(10)70325-2. - DOI - PMC - PubMed
    1. Liao F., Yoon H., Kim J. Apolipoprotein E metabolism and functions in brain and its role in Alzheimer’s disease. Curr. Opin. Lipidol. 2017;28:60–67. doi: 10.1097/MOL.0000000000000383. - DOI - PMC - PubMed
    1. Flowers S.A., Rebeck G.W. APOE in the Normal Brain. Neurobiol. Dis. 2020;136:104724. doi: 10.1016/j.nbd.2019.104724. - DOI - PMC - PubMed
    1. Yamazaki Y., Zhao N., Caulfield T.R., Liu C.-C., Bu G. Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies. Nat. Rev. Neurol. 2019;15:501–518. doi: 10.1038/s41582-019-0228-7. - DOI - PMC - PubMed
    1. Gharbi-Meliani A., Dugravot A., Sabia S., Regy M., Fayosse A., Schnitzler A., Kivimäki M., Singh-Manoux A., Dumurgier J. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study. Alzheimer’s Res. Ther. 2021;13:5. doi: 10.1186/s13195-020-00740-0. - DOI - PMC - PubMed

Grants and funding

LinkOut - more resources